PALM BEACH, Fla. – The first day of the National Association of Chain Drug Stores Annual Meeting got off to a fast start at a breakfast on GLP-1s sponsored by retailmediaIQ, publisher of Chain Drug Review and MMR. Building on a webinar devoted to the same topic earlier this year, the session addressed the latest developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors. Moderated by Parag Shah, co-founder, partner and chief growth officer at Think Blue, the panelists included Jim Kirby, chief commercial officer at Kroger Health, Betty Pio, a partner and strategic advisor to pharma and biotech at Kearney, and Sarah Squires, director of Retail Insights Drug Channel at NielsenIQ.
CDR/MMR breakfast at NACDS Annual looks at the latest developments in GLP-1 category
The session addressed the latest GLP-1 developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors.
Latest
Supreme Court temporarily keeps abortion pill available
An order issued Monday by Justice Samuel Alito keeps existing access in place until at least Thursday, allowing the pill to continue to be obtained at pharmacies or by mail without an in‑person doctor visit.
Rogue raises $2.5M and secures launch in 2,800 Walmart stores nationwide
Rogue will launch online in early May and nationally in 2,800 Walmart stores in July, securing placement in the protein/sports nutrition aisle.
Circana: U.S. beauty market delivers steady first quarter growth
Value consciousness, treatment‑led demand, and digital acceleration shape performance.
Marty Makary’s future at the FDA hangs in the balance
Reports that President Trump approved plans to remove FDA Commissioner Marty Makary have fueled uncertainty around the agency as disputes over vaping, abortion pills and drug approvals intensify.